| Per Andersen
| University of Copenhagen, Denmark |
| Sanjib Basu
| University of Illinois at Chicago, USA |
| Michael Brammer
| King's College London, UK |
| Marc Buyse
| International Drug Development Institute, Belgium |
| James Carpenter
| Ann Arbor, Michigan, USA |
| K.C. Carriere
| University of Alberta, USA |
| Eric Chi
| North Carolina State University, USA |
| Itai Dattner
| University of Haifa, Israel |
| Daniela De Angelis
| University of Cambridge, UK |
| Stephen Duffy
| Queen Mary University of London, UK |
| Lisa Hampson
| Novartis Pharma AG, Switzerland |
| Brian Healy
| Harvard Medical School, USA |
| Theodore Holford
| Yale University, USA |
| C Jennison
| University of Bath, UK |
| Byron Jones
| Pfizer Global Research and Development, USA |
| Mark Kelson
| Exeter University, UK |
| Sabine Landau
| King's College London, UK |
| Kenneth Lange
| University of California, Los Angeles, USA |
| Andrew B Lawson
| Medical University of South Carolina, USA |
| Morven Leese
| King's College London, UK |
| Ruosha Li
| The University of Texas Health Science Center at Houston, USA |
| Zhigang Li
| University of Florida, USA |
| Xiaomei Liao
| Harvard University, USA |
| Ruitao Lin
| The University of Texas MD Anderson Cancer Center, USA |
| Aiyi Liu
| NICHD/NIH, USA |
| Tanzy Love
| University of Rochester, USA |
| Glen Martin
| University of Manchester, UK |
| Ben Reiser
| University of Haifa, Israel |
| Abdus Sattar
| Case Western Reserve University, USA |
| Stephen Senn
| Consultant Statistician, Edinburgh |
| Daniel Stahl
| King's College London, UK |
| Nigel Stallard
| University of Warwick, UK |
| Andrew Titman
| Lancaster University, UK |
| Brian D.M. Tom
| MRC Biostatistics Unit, UK |
| Mark van der Laan
| University of California, USA |
| Bo Wang
| North Carolina A&T State University, USA |
| James Wason
| Newcastle University, UK |
| Ian White
| MRC Clinical Trials Unit at UCL, UK |
| Tu Xu
| Novo Nordisk, USA |
| Guan Yu
| University of Pittsburgh, USA |
| Bo Zhang
| Harvard Medical School, USA |